Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ACGJ about 3.9 m float ** pps 0023 *** very undervalued. Still wait for reverse merger news. Probably 5000-10.000% stock for me.
yes hold'n ACGJ. this value is complete undervalued @0023
ACGJ 15% up. Nice week start now
ACGJ 002 BREAKING OUT 400%!!!!! 3.9M FLOAT
ACGJ without dilution 5 years ago. Could be next low float multi penny run. Watchlist.
But why the hell this extreme bid/ask buying interest?
Can't find any nl alert so far
i will contact company tomorrow. Hope for response very soon.
ACGJ is breaking out. 400% up friday. Based on 3.9 milion float and 002 pps a strong buy for monday.
ACGJ is breaking out. 400% up friday. Based on 3.9 milion float and 002 pps a strong buy for monday.
Hope we're rigth here. Goooo.. ACGJ
Me too.
ACGJ is a possible big mover this week.
R/M update this week and we earn a ton of $$$
100% agree with you
and 500k buy 0024. Looking realy good.
L2 showing big. Thats make me hopefull for great week with ACGJ
Tomorrow is show time.
She is waking
500k ask buy @0024. Ask is very very thin
Yes 1.5-2 milion bid support 0017-0018. Thats strong
Watch the share structure. Complete undervalued @002
ACGJ is a reverse merger lotto. Could easy run few 1000% next week.
Solid base for another up leg monday
Solid base for another up leg monday
Strong 0017-0024 trading volume yesterday.
Aci Global Corp (ACGJ) Key Developments Pacgen Biopharmaceuticals Corporation Signs an Amendment to its License Agreement with ACI Global Corporation Jan 30 12 Pacgen Biopharmaceuticals Corporation announced that the company has signed an amendment to its license agreement with ACI Global Corporation to expand its exclusive worldwide rights and license to PAC-113 for additional indications, including vaginal, dermatological and ophthalmic applications. There was no payment associated with the amendment license agreement. All other terms of the license agreement remained unchanged. Pacgen has right to sublicense all these additional indications as well as oral indications covered in its original license.
52Wk High
0.0049 (-59.18%)
Since 11/02/11
002 +400% close. Awesome
$$$$$$$$$$ ACGJ 0017X002 BREAKOUT ALERT $$$$$$$$$$$$$$
$$$$$$$$$$ ACGJ 0017X002 BREAKOUT ALERT $$$$$$$$$$$$$$
ACGJ 96K left @0023 73k@0024 50k@0029
ACGJ +475% 0023 3.9M FLOAT. BREAKOUT STOCK. RADAR
ACGJ 0023 1 left. +475% 3.9m float Low floater moving up. Watchlist
ACGJ 0017X0024 78K left 325% up so far.
ACGJ 0017X0024 78K left 325% up so far.
SWMX 005
SWMX 005 +150% ready to go
SWMX watchlist